No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3147-3150

  Maeda, Shingo ^a   Saikawa, Yoshiro ^a   Kubota, Tetsuro ^a   Aoki, Masahiko ^a   Otani, Yoshihide ^a   Furukawa, Toshiharu ^a   Watanabe, Masahiko ^a   Kumai, Koichiro ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Gastric cancer; MTT assay; Taxol; Taxotere

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS RESISTANCE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLUOROURACIL; HUMANS; MALE; MITOMYCIN; PACLITAXEL; STOMACH NEOPLASMS; TAXOIDS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0041528193     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hundahl SA: Surgical quality control in gastric cancer thais trials. Surg Oncol N Am I1: 445-458, 2002.
2. Comis RI and Carter SK: Integration of chemotherapy into combined modality treatment of solid tumors. III Gastric cancer. Cancer Treat Rev 1: 221-238, 1974.
3. Schipper DL and Wagener DJT: Chemotherapy of gastric cancer. Anticancer Drugs 7: 137-149, 1995.
4. Hu JK, Chen ZX, Zhou ZG et al: Intravenous chemotherapy for resected gastric cancer. Meta-analysis of randomized controlled trials. World J Gastroenterol 8: 1023-1028, 2002.
5. Suto A, Kubota T, Shimoyama Y et al: MTT assay with reference to the clinical effect of chemotherapy. J Surg Oncol 42: 28-32, 1989.
6. Furukawa T, Kubota T, Suto A et al: Clinical usefulness of chemosensitivity testing using the MTT assay. J Surg Oncol 48: 188-193, 1991.
7. Saikawa Y, Kubota T, Furukawa T et al: Single-cell suspension assay with MTT endpoint is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. Jpn J Cancer Res 85: 762-765, 1994.
8. J Van Oosterom AT and Schrijvers D: Docetaxel (Taxotere): a review of preclinical and clinical experience. Part II: clinicai experience. Anticancer Drugs 6: 356-368, 1995.
9. Gelmon K: Pactitaxel and docetaxel. The Lancet 344: 1267-1272, 1994.
10. Mosmann T: Rapid colorimetirc assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J lmmunol Methods 65: 55-63, 1983.
11. Japanese Classification of Gastric Carcinoma, the 13th Edition. Tokyo: Kanehara & Co. Ltd, 1999.
12. Peto R, Pike MC, Armitage P et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II, Analysis and examples. Br J Cancer 35: 1-39, 1977.
13. Ringel I and Horvitz SB: Studies with RP56976 (Taxotere): a semi-synthetic analog of taxol. J Natl Cancer Inst 83: 288-291, 1991.
14. Gueritte-Voegelein F, Guenard D, Lavelle F et al: Relationships between the structure of taxol analogues and their antimitotic activity, J Med Chem 34: 992-998, 1991.
15. Kim R, Ohi Y, Toge T et al: Taxotere activates transcription factor AP-1 in association with apoptotic cell death in gastric cancer cell lines, Anticancer Res 19: 5399-5406, 1999.